Cefcrest-CV 625 Tablet
Marketer
Winsome Bioceuticals
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Cefcrest-CV 625 Tablet
Cefcrest-CV 625 tablets combat various bacterial infections by inhibiting microbial growth and propagation. This prescription medication should be taken precisely as directed. Consumption with or without food is acceptable, but consistent timing is crucial for optimal results. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken upon recollection. Complete the entire treatment course, even with symptom improvement; premature cessation may reduce effectiveness. Common side effects include nausea, vomiting, diarrhea, and indigestion. Consult a physician immediately if side effects worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, breathlessness, etc.). Inform your doctor of all other medications before initiating treatment. Pregnant or lactating individuals must consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration contribute to faster recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Cefcrest-CV 625 Tablet
No information provided. A rephrased version cannot be created.
Uses of Cefcrest-CV 625 Tablet
Combating Bacterial Infections
Major Benefits of Cefcrest-CV 625 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cefcrest-CV 625 Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Cefcrest-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Cefcrest-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Cefcrest-CV 625 Tablets can be ingested with or without food, however, consistent timing is recommended.
How Cefcrest-CV 625 Tablet works:
Cefuroxime and Clavulanic Acid, combined as Cefcrest-CV 625 Tablets, offer a dual-action approach to bacterial infections. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Clavulanic acid, a beta-lactamase inhibitor, counters bacterial enzymes that would otherwise neutralize Cefuroxime's effect. This synergistic combination broadens Cefuroxime's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Cefcrest-CV 625 Tablets poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Cefcrest-CV 625 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; however, research involving human subjects is restricted.
Breast feedingSAFE IF PRESCRIBED
Use of Cefcrest-CV 625 Tablets during lactation is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingNOT RELEVANT
Cefcrest-CV 625 Tablet is unsuitable for non-hospitalized individuals.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefcrest-CV 625 Tablet use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefcrest-CV 625 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cefcrest-CV 625 Tablet :
Should you forget a Cefcrest-CV 625 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cefcrest-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |


